The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System
暂无分享,去创建一个
R. Traub | Pei Wang | D. Cao | Si-Qi Wei | Zhuo-Ying Tao | Jin-Feng Li | Si-qi Wei
[1] M. Neumeister,et al. Fibromyalgia. , 2020, Clinics in plastic surgery.
[2] Imen Ayouni,et al. Comorbidity between fibromyalgia and temporomandibular disorders: a systematic review. , 2019, Oral surgery, oral medicine, oral pathology and oral radiology.
[3] Tao Yang,et al. Rostral ventromedial medulla‐mediated descending facilitation following P2X7 receptor activation is involved in the development of chronic post‐operative pain , 2019, Journal of neurochemistry.
[4] Xi Xiao,et al. MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7. , 2019, Biochemical and biophysical research communications.
[5] R. Ohrbach,et al. Characteristics Associated With High-Impact Pain in People With Temporomandibular Disorder: A Cross-Sectional Study. , 2019, The journal of pain : official journal of the American Pain Society.
[6] Yang Xue,et al. Spinal 5-HT3 receptor contributes to somatic hyperalgesia induced by sub-chronic stress , 2019, Molecular pain.
[7] F. Fregni,et al. Potency of descending pain modulatory system is linked with peripheral sensory dysfunction in fibromyalgia , 2019, Medicine.
[8] Blair H. Smith,et al. The IASP classification of chronic pain for ICD-11: applicability in primary care , 2019, Pain.
[9] S. Witt,et al. Interactions between gut permeability and brain structure and function in health and irritable bowel syndrome , 2018, NeuroImage: Clinical.
[10] A. Artola,et al. 5-HT2A Receptor-Induced Morphological Reorganization of PKCγ-Expressing Interneurons Gates Inflammatory Mechanical Allodynia in Rat , 2018, The Journal of Neuroscience.
[11] J. Grau,et al. Ionic plasticity and pain: The loss of descending serotonergic fibers after spinal cord injury transforms how GABA affects pain , 2018, Experimental Neurology.
[12] R. Khoury,et al. The role of 5 HT6-receptor antagonists in Alzheimer’s disease: an update , 2018, Expert opinion on investigational drugs.
[13] Jian Wang,et al. Top-down descending facilitation of spinal sensory excitatory transmission from the anterior cingulate cortex , 2018, Nature Communications.
[14] Aihui Li,et al. Electroacupuncture alleviates chemotherapy‐induced pain through inhibiting phosphorylation of spinal CaMKII in rats , 2018, European journal of pain.
[15] P. Martelletti,et al. Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential , 2018, Journal of pain research.
[16] N. Üçeyler,et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia , 2018, The Cochrane database of systematic reviews.
[17] O. Gunduz,et al. Contribution of spinal 5-HT5A receptors to the antinociceptive effects of systemically administered cannabinoid agonist WIN 55,212-2 and morphine. , 2018, Canadian journal of physiology and pharmacology.
[18] Asensi Cabo-Meseguer,et al. Fibromialgia: prevalencia, perfiles epidemiológicos y costes económicos , 2017 .
[19] N. Waszkiewicz,et al. Antidepressants for irritable bowel syndrome—A systematic review , 2017, Pharmacological reports : PR.
[20] H. Obata. Analgesic Mechanisms of Antidepressants for Neuropathic Pain , 2017, International journal of molecular sciences.
[21] A. Eschalier,et al. Disruption of 5-HT2A-PDZ protein interaction differently affects the analgesic efficacy of SSRI, SNRI and TCA in the treatment of traumatic neuropathic pain in rats , 2017, Neuropharmacology.
[22] E. Lacivita,et al. The brain-penetrant 5-HT7 receptor agonist LP-211 reduces the sensory and affective components of neuropathic pain , 2017, Neurobiology of Disease.
[23] O. Lyubashina,et al. The 5-HT4 receptor-mediated inhibition of visceral nociceptive neurons in the rat caudal ventrolateral medulla , 2017, Neuroscience.
[24] C. Bandala,et al. Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System , 2017, Current neuropharmacology.
[25] J. Rodríguez-Silverio,et al. Spinal 5-HT_4 and 5-HT_6 receptors contribute to the maintenance of neuropathic pain in rats , 2017, Pharmacological reports : PR.
[26] H. Choo,et al. Neuropathic pain-alleviating effects of pyrazole-conjugated arylsulfonamides as 5-HT6 receptor antagonists. , 2017, Bioorganic & medicinal chemistry letters.
[27] F. Brocard,et al. Activation of 5-HT2A Receptors Restores KCC2 Function and Reduces Neuropathic Pain after Spinal Cord Injury , 2017, Neuroscience.
[28] E. Verdú,et al. Neuroplasticity of Supraspinal Structures Associated with Pathological Pain , 2017, Anatomical record.
[29] M. Low,et al. Lorcaserin improves glycemic control via a melanocortin neurocircuit , 2017, Molecular metabolism.
[30] Josephine M. Mancuso,et al. Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis , 2017, Journal of General Internal Medicine.
[31] M. Zhuo,et al. Characterization of serotonin-induced inhibition of excitatory synaptic transmission in the anterior cingulate cortex , 2017, Molecular Brain.
[32] A. Pertovaara,et al. The medullary dorsal reticular nucleus as a relay for descending pronociception induced by the mGluR5 in the rat infralimbic cortex , 2017, Neuroscience.
[33] R. Chou,et al. Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline , 2017, Annals of Internal Medicine.
[34] A. Dickenson,et al. An investigation into the inhibitory function of serotonin in diffuse noxious inhibitory controls in the neuropathic rat , 2017, European journal of pain.
[35] A. Eschalier,et al. Increasing spinal 5‐HT2A receptor responsiveness mediates anti‐allodynic effect and potentiates fluoxetine efficacy in neuropathic rats. Evidence for GABA release , 2017, Pharmacological research.
[36] A. D. Nozdrachev,et al. Antinociceptive effect of the agonist of 5-HT1A receptors buspirone in the model of abdominal pain in dogs , 2017, Doklady Biological Sciences.
[37] V. Neugebauer,et al. 5-HT2C Receptor Knockdown in the Amygdala Inhibits Neuropathic-Pain-Related Plasticity and Behaviors , 2017, The Journal of Neuroscience.
[38] A. Pertovaara,et al. Descending antinociception induced by secondary somatosensory cortex stimulation in experimental neuropathy: role of the medullospinal serotonergic pathway. , 2017, Journal of neurophysiology.
[39] N. Coimbra,et al. 5-Hydroxytryptamine2A/2C receptors of nucleus raphe magnus and gigantocellularis/paragigantocellularis pars α reticular nuclei modulate the unconditioned fear-induced antinociception evoked by electrical stimulation of deep layers of the superior colliculus and dorsal periaqueductal grey matter , 2017, Behavioural Brain Research.
[40] R. Lewis‐Fernández,et al. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder , 2016, Journal of clinical psychopharmacology.
[41] J. Fiedler,et al. What Do We Really Know About 5-HT1A Receptor Signaling in Neuronal Cells? , 2016, Front. Cell. Neurosci..
[42] A. U. Khan,et al. The μ1-opioid receptor and 5-HT2A- and 5HT2C-serotonergic receptors of the locus coeruleus are critical in elaborating hypoalgesia induced by tonic and tonic–clonic seizures , 2016, Neuroscience.
[43] R. Dong,et al. The 5-HT2A receptor potassium-chloride cotransporter 2 signaling pathway in a rat incision pain model , 2016, Experimental and therapeutic medicine.
[44] M. Sulaiman,et al. Zerumbone alleviates chronic constriction injury-induced allodynia and hyperalgesia through serotonin 5-HT receptors. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[45] P. Svensson,et al. Headaches and myofascial temporomandibular disorders: overlapping entities, separate managements? , 2016, Journal of oral rehabilitation.
[46] V. Granados-Soto,et al. Role of 5-HT5A and 5-HT1B/1D receptors in the antinociception produced by ergotamine and valerenic acid in the rat formalin test. , 2016, European journal of pharmacology.
[47] V. Granados-Soto,et al. Role of spinal 5-HT_2 receptors subtypes in formalin-induced long-lasting hypersensitivity , 2016, Pharmacological reports : PR.
[48] P. Siddall,et al. Descending pain modulation in irritable bowel syndrome (IBS): a systematic review and meta-analysis , 2015, Systematic Reviews.
[49] Wei-Hsin Sun,et al. Serotonin Receptor 2B Mediates Mechanical Hyperalgesia by Regulating Transient Receptor Potential Vanilloid 1 , 2015, Journal of Molecular Neuroscience.
[50] M. Ernberg,et al. Repeated tender point injections of granisetron alleviate chronic myofascial pain - a randomized, controlled, double-blinded trial , 2015, The Journal of Headache and Pain.
[51] V. Granados-Soto,et al. Role of spinal 5-HT5A, and 5-HT1A/1B/1D, receptors in neuropathic pain induced by spinal nerve ligation in rats , 2015, Brain Research.
[52] E. Calandre,et al. Amitriptyline for the treatment of fibromyalgia: a comprehensive review , 2015, Expert review of neurotherapeutics.
[53] T. Ness,et al. Serotonin enhances urinary bladder nociceptive processing via a 5-HT3 receptor mechanism , 2015, Neuroscience Letters.
[54] R. Nirogi,et al. 5-HT_6 receptor antagonist attenuates the memory deficits associated with neuropathic pain and improves the efficacy of gabapentinoids , 2015, Pharmacological reports : PR.
[55] Lin Lin,et al. Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis , 2015, PloS one.
[56] G. Úrrutia,et al. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. , 2015, The Cochrane database of systematic reviews.
[57] R. Sterzi,et al. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults. , 2015, The Cochrane database of systematic reviews.
[58] R. Miledi,et al. Expression of hippocampal serotonin receptors 5-HT2C and 5-HT5A in a rat model of diet-induced obesity supplemented with tryptophan , 2015, International Journal of Developmental Neuroscience.
[59] T. Schwartz,et al. Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1. , 2015, ACS chemical neuroscience.
[60] G. Dobos,et al. Somatoform disorders and medically unexplained symptoms in primary care. , 2015, Deutsches Arzteblatt international.
[61] A. Pertovaara,et al. Bidirectional amygdaloid control of neuropathic hypersensitivity mediated by descending serotonergic pathways acting on spinal 5-HT3 and 5-HT1A receptors , 2015, Behavioural Brain Research.
[62] Blair H. Smith,et al. A classification of chronic pain for ICD-11 , 2015, Pain.
[63] D. Lucini,et al. Autonomic nervous system dysregulation in irritable bowel syndrome , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[64] P. Rhee,et al. The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D) , 2015, Therapeutic advances in gastroenterology.
[65] V. Granados-Soto,et al. 5‐HT2B Receptor Antagonists Reduce Nerve Injury‐Induced Tactile Allodynia and Expression of 5‐HT2B Receptors , 2015, Drug development research.
[66] Zhi Xiao,et al. Antihyperalgesic effect of 5-HT7 receptor activation on the midbrain periaqueductal gray in a rat model of neuropathic pain , 2014, Pharmacology Biochemistry and Behavior.
[67] A. Dickenson,et al. Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[68] L. Bulathsinhala,et al. Prevalence, health care utilization, and costs of fibromyalgia, irritable bowel, and chronic fatigue syndromes in the military health system, 2006-2010. , 2014, Military medicine.
[69] B. Cagnie,et al. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. , 2014, Seminars in arthritis and rheumatism.
[70] H. Bae,et al. Different role of spinal 5-HT(hydroxytryptamine)7 receptors and descending serotonergic modulation in inflammatory pain induced in formalin and carrageenan rat models. , 2014, British journal of anaesthesia.
[71] F. Porreca,et al. Descending pain modulation and chronification of pain , 2014, Current opinion in supportive and palliative care.
[72] S. Fukudo,et al. Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[73] P. Henningsen,et al. Irritable bowel syndrome: relations with functional, mental, and somatoform disorders. , 2014, World journal of gastroenterology.
[74] V. Granados-Soto,et al. Spinal 5-HT5A receptors mediate 5-HT-induced antinociception in several pain models in rats , 2014, Pharmacology Biochemistry and Behavior.
[75] R. von Känel,et al. Hypersensitivity and hyperalgesia in somatoform pain disorders. , 2014, General hospital psychiatry.
[76] Y. Ha,et al. Role of the 5-HT7 receptor in the effects of intrathecal nefopam in neuropathic pain in rats , 2014, Neuroscience Letters.
[77] B. Tas,et al. The TRPM8 channel forms a complex with the 5-HT1B receptor and phospholipase D that amplifies its reversal of pain hypersensitivity , 2014, Neuropharmacology.
[78] R. Shaker,et al. Visceral analgesic effect of 5-HT4 receptor agonist in rats involves the rostroventral medulla (RVM) , 2014, Neuropharmacology.
[79] Andrew W Bundeff,et al. Selective Serotonin Reuptake Inhibitors for the Treatment of Irritable Bowel Syndrome , 2014, The Annals of pharmacotherapy.
[80] P. Wiffen,et al. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. , 2014, The Cochrane database of systematic reviews.
[81] W. Guo,et al. Spinal 5-HT3 receptors mediate descending facilitation and contribute to behavioral hypersensitivity via a reciprocal neuron-glial signaling cascade , 2014, Molecular pain.
[82] M. Franzen,et al. An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder , 2014, International journal of psychiatry in clinical practice.
[83] N. Coimbra,et al. The role of dorsomedial and ventrolateral columns of the periaqueductal gray matter and in situ 5‐HT2A and 5‐HT2C serotonergic receptors in post‐ictal antinociception , 2014, Synapse.
[84] V. Granados-Soto,et al. Peripheral and spinal 5-HT receptors participate in the pronociceptive and antinociceptive effects of fluoxetine in rats , 2013, Neuroscience.
[85] A. Eschalier,et al. Disruption of 5-HT2A Receptor-PDZ Protein Interactions Alleviates Mechanical Hypersensitivity in Carrageenan-Induced Inflammation in Rats , 2013, PloS one.
[86] A. Meneses,et al. Role of 5-HT5A receptors in the consolidation of memory , 2013, Behavioural Brain Research.
[87] M. Zimmermann,et al. Transient, 5-HT2B receptor–mediated facilitation in neuropathic pain: Up-regulation of PKCγ and engagement of the NMDA receptor in dorsal horn neurons , 2013, PAIN®.
[88] L. Queiroz. Worldwide Epidemiology of Fibromyalgia , 2013, Current Pain and Headache Reports.
[89] I. Choi,et al. 5-Hydroxytryptamine 1A receptors inhibit glutamate release in rat medullary dorsal horn neurons , 2013, Neuroreport.
[90] V. Neugebauer,et al. 5-HT2CR blockade in the amygdala conveys analgesic efficacy to SSRIs in a rat model of arthritis pain , 2013, Molecular pain.
[91] Rémi Bos,et al. Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2 , 2012, Proceedings of the National Academy of Sciences.
[92] Alexander C. Ford. Acupuncture for irritable bowel syndrome. , 2012, Gastroenterology.
[93] M. Hamon,et al. GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain , 2012, Neuropharmacology.
[94] V. Granados-Soto,et al. Secondary mechanical allodynia and hyperalgesia depend on descending facilitation mediated by spinal 5-HT4, 5-HT6 and 5-HT7 receptors , 2012, Neuroscience.
[95] M. Zimmermann,et al. Time-Dependent Cross Talk between Spinal Serotonin 5-HT2A Receptor and mGluR1 Subserves Spinal Hyperexcitability and Neuropathic Pain after Nerve Injury , 2012, The Journal of Neuroscience.
[96] F. Wolfe,et al. The Role of Antidepressants in the Management of Fibromyalgia Syndrome , 2012, CNS Drugs.
[97] C. Jatzke,et al. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression , 2012, Behavioural pharmacology.
[98] A. Ford,et al. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[99] H. Diener,et al. Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study , 2012, The Lancet Neurology.
[100] J. Galligan,et al. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. , 2012, Gastroenterology.
[101] V. Tayal,et al. Efficacy of Antidepressants as Analgesics: A Review , 2012, Journal of clinical pharmacology.
[102] C. Sohn,et al. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[103] H. Kim,et al. Formulation optimization of solid dispersion of mosapride hydrochloride , 2011, Archives of pharmacal research.
[104] V. Granados-Soto,et al. Blockade of 5-HT7 receptors reduces tactile allodynia in the rat , 2011, Pharmacology Biochemistry and Behavior.
[105] J. Clark,et al. 5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice. , 2011, Anesthesiology.
[106] Pascale Vergne-Sallel,et al. A randomised, double‐blind, placebo‐controlled trial of dolasetron, a 5‐hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia , 2011, European journal of pain.
[107] G. Haegeman,et al. Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives , 2011, Molecular Neurobiology.
[108] E. Lacivita,et al. Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. , 2011, Pharmacology & therapeutics.
[109] L. Arendt-Nielsen,et al. Endogenous descending modulation: spatiotemporal effect of dynamic imbalance between descending facilitation and inhibition of nociception , 2010, The Journal of physiology.
[110] J. Schoenen,et al. EFNS guideline on the treatment of tension‐type headache – Report of an EFNS task force , 2010, European journal of neurology.
[111] A. Eschalier,et al. Disrupting 5-HT2A Receptor/PDZ Protein Interactions Reduces Hyperalgesia and Enhances SSRI Efficacy in Neuropathic Pain. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[112] M. Zimmermann,et al. Subtype-specific changes in 5-HT receptor-mediated modulation of C fibre-evoked spinal field potentials are triggered by peripheral nerve injury , 2010, Neuroscience.
[113] J. Rosmalen,et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders , 2010, Biological Psychology.
[114] L. Romero,et al. Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity , 2010, PAIN.
[115] T. Dinan,et al. 5‐HT2B receptors modulate visceral hypersensitivity in a stress‐sensitive animal model of brain‐gut axis dysfunction , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[116] A. Dickenson,et al. Preclinical and early clinical investigations related to monoaminergic pain modulation , 2009, Neurotherapeutics.
[117] V. Granados-Soto,et al. Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test , 2009, Neuroscience.
[118] M. Murad,et al. Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis. , 2009, JAMA.
[119] David A. Williams,et al. Understanding fibromyalgia: lessons from the broader pain research community. , 2009, The journal of pain : official journal of the American Pain Society.
[120] K. Tominaga,et al. Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients With Functional Dyspepsia: A Randomized Controlled Trial , 2009, The American Journal of Gastroenterology.
[121] F. Porreca,et al. Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors , 2009, Brain Research.
[122] J. V. Steenwinckel,et al. The 5-HT2A receptor is mainly expressed in nociceptive sensory neurons in rat lumbar dorsal root ganglia , 2009, Neuroscience.
[123] B. P. Brennan,et al. Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study , 2009, Human psychopharmacology.
[124] N. Coimbra,et al. 5-HT1A/1B, 5-HT6, and 5-HT7 serotonergic receptors recruitment in tonic-clonic seizure-induced antinociception: Role of dorsal raphe nucleus , 2009, Experimental Neurology.
[125] Roja Rahimi,et al. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. , 2009, World journal of gastroenterology.
[126] L. Weaver,et al. Blockade of the 5‐HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury , 2009, Journal of neuroscience research.
[127] A. Dolphin,et al. Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain , 2009, Molecular pain.
[128] C. Qu,et al. GABAergic modulation is involved in the ventrolateral orbital cortex 5-HT1A receptor activation-induced antinociception in the rat , 2008, PAIN.
[129] N. Coimbra,et al. Serotonergic neurotransmission in the dorsal raphe nucleus recruits in situ 5-HT2A/2C receptors to modulate the post-ictal antinociception , 2008, Experimental Neurology.
[130] Louis P. Vera-Portocarrero,et al. Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan. , 2008, Gastroenterology.
[131] M. Kawamura,et al. The Antiallodynic Effect of Neurotropin® Is Mediated via Activation of Descending Pain Inhibitory Systems in Rats with Spinal Nerve Ligation , 2008, Anesthesia and analgesia.
[132] W. Bauer,et al. Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats , 2008, Brain Research.
[133] B. Löwe,et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. , 2008, General hospital psychiatry.
[134] J. Hoving,et al. Antidepressants for non-specific low back pain. , 2008, The Cochrane database of systematic reviews.
[135] M. Connor,et al. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey , 2008, Molecular pain.
[136] Lei Dong,et al. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome. , 2007, Chinese medical journal.
[137] D. Bouhassira,et al. Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation 1 , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[138] M. Sasamata,et al. Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats. , 2007, European journal of pharmacology.
[139] D. Julius,et al. Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice , 2007, PAIN.
[140] M. Seidel,et al. 5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome , 2007, Rheumatology International.
[141] H. Obata,et al. Possible involvement of spinal noradrenergic mechanisms in the antiallodynic effect of intrathecally administered 5-HT2C receptor agonists in the rats with peripheral nerve injury. , 2007, European journal of pharmacology.
[142] J. Rietdorf,et al. Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C,5-HT3D, and 5-HT3E , 2007, Molecular Pharmacology.
[143] Jisheng Han,et al. Roles of 5-Hydroxytryptamine (5-HT) Receptor Subtypes in the Inhibitory Effects of 5-HT on C-Fiber Responses of Spinal Wide Dynamic Range Neurons in Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.
[144] Robert W Gereau,et al. Mice Lacking Central Serotonergic Neurons Show Enhanced Inflammatory Pain and an Impaired Analgesic Response to Antidepressant Drugs , 2007, The Journal of Neuroscience.
[145] Peter Henningsen,et al. Management of functional somatic syndromes , 2007, The Lancet.
[146] A. Dogrul,et al. Systemic morphine produce antinociception mediated by spinal 5‐HT7, but not 5‐HT1A and 5‐HT2 receptors in the spinal cord , 2006, British journal of pharmacology.
[147] M. Tanabe,et al. Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors , 2006, Neuropharmacology.
[148] H. Obata,et al. Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats , 2006, PAIN.
[149] A. Dickenson,et al. Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone pain , 2006, Neuroscience Letters.
[150] J. Tack,et al. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome , 2005, Gut.
[151] D. Vergé,et al. Pre‐ and postsynaptic localization of the 5‐HT7 receptor in rat dorsal spinal cord: Immunocytochemical evidence , 2005, The Journal of comparative neurology.
[152] T. Jensen,et al. Antidepressants in the treatment of neuropathic pain. , 2005, Basic & clinical pharmacology & toxicology.
[153] H. Toda,et al. Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agent. , 2005, Bioorganic & medicinal chemistry letters.
[154] Rie Suzuki,et al. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. , 2004, Trends in pharmacological sciences.
[155] M. Christie,et al. Effects of sumatriptan on rat medullary dorsal horn neurons , 2004, Pain.
[156] D. Vergé,et al. 5‐HT5A receptor localization in the rat spinal cord suggests a role in nociception and control of pelvic floor musculature , 2004, The Journal of comparative neurology.
[157] D. Siniscalco,et al. Metabotropic glutamate receptor 5 and dorsal raphe serotonin release in inflammatory pain in rat. , 2004, European journal of pharmacology.
[158] A. Dickenson,et al. Descending serotonergic facilitation mediated through rat spinal 5HT3 receptors is unaltered following carrageenan inflammation , 2004, Neuroscience Letters.
[159] M. Nakashima,et al. Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain. , 2004, European journal of pharmacology.
[160] F. Colpaert,et al. Continuous Administration of the 5-Hydroxytryptamine1A Agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl}piperidin-1-yl]-methadone (F 13640) Attenuates Allodynia-Like Behavior in a Rat Model of Trigeminal Neuropathic Pain , 2003, Journal of Pharmacology and Experimental Therapeutics.
[161] D. Richter,et al. 5-HT4(a) Receptors Avert Opioid-Induced Breathing Depression Without Loss of Analgesia , 2003, Science.
[162] S. Wessely,et al. Medically Unexplained Symptoms: Exacerbating Factors in the Doctor-Patient Encounter , 2003, Journal of the Royal Society of Medicine.
[163] F. Colpaert,et al. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640. , 2003, European journal of pharmacology.
[164] Winfried Rief,et al. A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. , 2003, Journal of psychosomatic research.
[165] K. Lawson. Tricyclic antidepressants and fibromyalgia: what is the mechanism of action? , 2002, Expert opinion on investigational drugs.
[166] K. Hackshaw,et al. Reduced basal release of serotonin from the ventrobasal thalamus of the rat in a model of neuropathic pain , 2002, PAIN.
[167] P. Schoenfeld,et al. The epidemiology of irritable bowel syndrome in North America: a systematic review , 2002, American Journal of Gastroenterology.
[168] M. Millan. Descending control of pain , 2002, Progress in Neurobiology.
[169] P. Keck,et al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. , 2002, The American journal of medicine.
[170] A. Basbaum,et al. The 5-HT3 Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors , 2002, The Journal of Neuroscience.
[171] K. Hole,et al. Activation of spinal serotonin2A/2C receptors augments nociceptive responses in the rat , 2001, Brain Research.
[172] R Hen,et al. Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution. , 2001, European journal of pharmacology.
[173] H. Wolf. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists , 2000, Scandinavian journal of rheumatology. Supplement.
[174] T. Patterson,et al. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity , 1999, PAIN.
[175] S. Wessely,et al. Functional somatic syndromes: one or many? , 1999, The Lancet.
[176] Trevor Sharp,et al. A review of central 5-HT receptors and their function , 1999, Neuropharmacology.
[177] John A. Peters,et al. The 5-HT3B subunit is a major determinant of serotonin-receptor function , 1999, Nature.
[178] P. Szot,et al. Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing , 1998, Neuropharmacology.
[179] M. Zhuo,et al. Biphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the rat. , 1997, Journal of neurophysiology.
[180] C. Schmid,et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. , 1996, Arthritis and rheumatism.
[181] J. Olesen,et al. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[182] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[183] R. K. Price,et al. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. , 1993, Archives of internal medicine.
[184] D. Hoyer,et al. A proposed new nomenclature for 5-HT receptors. , 1993, Trends in pharmacological sciences.
[185] J. Schwartz,et al. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. , 1993, Biochemical and biophysical research communications.
[186] M. Erlander,et al. Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[187] M. Mattei,et al. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. , 1993, Molecular pharmacology.
[188] J. Levine,et al. A possible indicator of functional pain: poor pain scale correlation , 1991, Pain.
[189] J. Hsieh,et al. Neuroimaging Studies of Primary Dysmenorrhea. , 2018, Advances in experimental medicine and biology.
[190] U. Ladabaum,et al. Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[191] Antidepressants: suicidality risk is `strongly' age-related , 2009 .
[192] O. Plesh,et al. Temporomandibular joint and muscle disorder-type pain in U.S. adults: the National Health Interview Survey. , 2008, Journal of orofacial pain.
[193] T. Gan. Selective Serotonin 5-HT3 Receptor Antagonists for Postoperative Nausea and Vomiting , 2005, CNS drugs.
[194] I. Russell,et al. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. , 1992, The Journal of rheumatology.